These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32589494)

  • 1. Application of a likelihood ratio test based method for safety signal detection to left ventricular assist devices.
    Jung MY; Ward R; Xu Z; Xu J; Yao Z; Huang L; Tiwari R
    J Biopharm Stat; 2021 Jan; 31(1):47-54. PubMed ID: 32589494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review.
    Cho SM; Moazami N; Frontera JA
    Neurocrit Care; 2017 Aug; 27(1):17-25. PubMed ID: 28324260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating medical device adverse event signals using a likelihood ratio test method.
    Xu Z; Xu J; Yao Z; Huang L; Jung M; Tiwari R
    J Biopharm Stat; 2021 Jan; 31(1):37-46. PubMed ID: 32594849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective 1-year outcome follow-up in 200 patients supported with HeartMate 3 and HeartWare left ventricular assist devices in a single centre.
    Mueller M; Hoermandinger C; Richter G; Mulzer J; Tsyganenko D; Krabatsch T; Starck C; Stein J; Schoenrath F; Falk V; Potapov E
    Eur J Cardiothorac Surg; 2020 Jun; 57(6):1160-1165. PubMed ID: 32298426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?
    Florisson DS; Conte SM; De Bono JA; Newcomb AE
    Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and Readmissions After Continuous Flow Left Ventricular Assist Device: Heartmate II Versus Heartware Ventricular Assist Device.
    Tuncer ON; Kemaloğlu C; Erbasan O; Gölbaşı I; Türkay C; Bayezid Ö
    Transplant Proc; 2016; 48(6):2157-61. PubMed ID: 27569963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices.
    Mohamedali B; Yost G; Bhat G
    J Card Fail; 2015 Oct; 21(10):800-5. PubMed ID: 26093334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe LVAD-related infections requiring surgical treatment: Incidence, predictors, effect on survival, and impact of device selection.
    Olmsted RZ; Critsinelis A; Kurihara C; Kawabori M; Sugiura T; Civitello AB; Morgan JA
    J Card Surg; 2019 Feb; 34(2):82-91. PubMed ID: 30710496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
    Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal cannula positioning of HeartMate 3 left ventricular assist device.
    Imamura T; Narang N; Nitta D; Fujino T; Nguyen A; Kim G; Raikhelkar J; Rodgers D; Ota T; Jeevanandam V; Sayer G; Uriel N
    Artif Organs; 2020 Dec; 44(12):e509-e519. PubMed ID: 32557769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A network meta-analysis of randomized trials and observational studies on left ventricular assist devices in adult patients with end-stage heart failure.
    Cavarretta E; Marullo AGM; Sciarretta S; Benedetto U; Greco E; Roever L; Tonelli E; Peruzzi M; Iaccarino A; Biondi-Zoccai G; Frati G
    Eur J Cardiothorac Surg; 2019 Mar; 55(3):461-467. PubMed ID: 30137270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of stroke early after implantation of a left ventricular assist device.
    Samura T; Yoshioka D; Toda K; Sakaniwa R; Shimizu M; Miyagawa S; Yoshikawa Y; Hata H; Saito S; Sakata Y; Sawa Y
    J Thorac Cardiovasc Surg; 2019 Jan; 157(1):259-267.e1. PubMed ID: 30060931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of statin therapy on neurological events following left ventricular assist system implantation in advanced heart failure.
    Vieira JL; Pfeffer M; Claggett BL; Stewart GC; Givertz MM; Coakley L; Mallidi HR; Mehra MR
    J Heart Lung Transplant; 2020 Jun; 39(6):582-592. PubMed ID: 32220561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current results of left ventricular assist device therapy in France: the ASSIST-ICD registry.
    Anselmi A; Galand V; Vincentelli A; Boule S; Dambrin C; Delmas C; Barandon L; Pernot M; Kindo M; Tam HM; Gaudard P; Rouviere P; Senage T; Michel M; Boignard A; Chavanon O; Verdonk C; Para M; Gariboldi V; Pelce E; Pozzi M; Obadia JF; Anselme F; Litzler PY; Babatasi G; Belin A; Garnier F; Bielefeld M; Guihaire J; Kloeckner M; Radu C; Lellouche N; Bourguignon T; Genet T; D'Ostrevy N; Duband B; Jouan J; Bories MC; Vanhuyse F; Blangy H; Colas F; Verhoye JP; Martins R; Flecher E
    Eur J Cardiothorac Surg; 2020 Jul; 58(1):112-120. PubMed ID: 32298439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.